Cetroript-S 1.5 Injection
Marketer
Kript Pharmaceuticals Private Limited
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Cetroript-S 1.5 Injection
Combiflox 1.5 Injection, a multi-component medication, combats diverse bacterial infections. Its action inhibits microbial proliferation, curbing infection spread. Administration must be strictly under a doctor's guidance; missed appointments should be avoided. The entire treatment regimen must be completed, regardless of symptom improvement; premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and digestive upset. Worsening side effects necessitate immediate medical consultation. Allergic reactions (rash, itching, swelling, respiratory distress) demand urgent medical attention. Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals require prior medical approval. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occur. Adequate rest, balanced nutrition, and ample hydration promote recovery. Your doctor may order tests to monitor the medication's effects.
Primary Ingredients of Cetroript-S 1.5 Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Cetroript-S 1.5 Injection
Infections caused by bacteria
Major Benefits of Cetroript-S 1.5 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Cetroript-S 1.5 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cetroript-S 1.5 Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Cetroript-S 1.5 Injection works:
Ceftriaxone and Sulbactam, the components of Cetroript-S 1.5 Injection, act synergistically to combat bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, thereby inhibiting bacterial growth. Sulbactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Cetroript-S 1.5 Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Cetroript-S 1.5 is typically deemed safe for use during gestation. Preclinical trials using animal models revealed minimal or no harmful consequences to fetal development; nonetheless, clinical data from human trials are scarce.
Breast feedingCAUTION
The administration of Cetroript-S 1.5 Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until the mother's treatment concludes and the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Cetroript-S 1.5 Injection can induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cetroript-S 1.5 Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Cetroript-S 1.5 Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician. Dosage alteration for Cetroript-S 1.5 Injection is unnecessary in patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cetroript-S 1.5 Injection :
Should you inadvertently skip a Cetroript-S 1.5 Injection, seek medical advice from your physician.
Facts to Know About Cetroript-S 1.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently